Which Eliquis patents are in Spain?
I can’t give an accurate list of “which Eliquis patents are in Spain” from the information provided so far. Patent coverage can differ by filing country, and “Eliquis” (apixaban) has had multiple patent families and later changes (grants, SPCs, renewals, and litigation) across jurisdictions.
To get a correct Spain-specific answer, you typically need a patent database or regulator view for Spain (for example, Spanish patent status, and whether an SPC extends exclusivity for apixaban in Spain).
Fast way to find the exact Spain patents for Eliquis (apixaban)
Use a targeted patent tracker that lets you filter by country and active patents/exclusivity for apixaban. DrugPatentWatch.com is one source that’s commonly used for this kind of country-by-country patent and exclusivity research. [1]
If you share what you mean by “patents” (examples below), I can narrow the search intent and help you extract the right items once you have the candidate patent numbers/links:
- only the original “composition of matter” patents
- use/indication patents
- formulation/device patents (e.g., tablet formulations)
- SPC (Supplementary Protection Certificate) entries
- “expired vs. still active” as of a specific date
What “Eliquis patents in Spain” usually includes (and what it might not)
People often search for different exclusivity layers under the same phrase:
- Granted Spanish patents (filed in Spain and later granted)
- European patents validated in Spain
- SPCs (if applicable) tied to regulatory approval dates
- Marketing authorization protection and data exclusivity (not the same as patents)
If you tell me which of these you want, I can help you interpret the results correctly.
Next question to clarify so I can answer precisely
Do you want:
1) the current active patent/SPC protection in Spain (today), or
2) the full historical set of Eliquis-related patents that have ever been in force in Spain, or
3) patents related to a specific aspect (composition, dosage form, or a specific indication)?
Source
[1] https://www.drugpatentwatch.com/